Go Pro

Tilray Brands (TLRY) Competitors

Tilray Brands logo
$4.46 +0.04 (+0.90%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$4.44 -0.02 (-0.45%)
As of 07/13/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TLRY vs. ACB, CGC, CRON, OGI, and SNDL

Should you buy Tilray Brands stock or one of its competitors? MarketBeat compares Tilray Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tilray Brands include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry.

How does Tilray Brands compare to Aurora Cannabis?

Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

Aurora Cannabis has a net margin of -33.57% compared to Tilray Brands' net margin of -156.51%. Aurora Cannabis' return on equity of 0.10% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-156.51% -3.31% -2.42%
Aurora Cannabis -33.57%0.10%0.07%

Tilray Brands has a beta of 1.89, suggesting that its share price is 89% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$821.31M0.63-$2.19B-$13.65N/A
Aurora Cannabis$247.82M0.66-$88.13M-$1.56N/A

In the previous week, Tilray Brands had 15 more articles in the media than Aurora Cannabis. MarketBeat recorded 21 mentions for Tilray Brands and 6 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.78 beat Aurora Cannabis' score of 0.24 indicating that Tilray Brands is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
10 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Tilray Brands currently has a consensus target price of $11.50, indicating a potential upside of 157.85%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities research analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Tilray Brands beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Tilray Brands has a consensus price target of $11.50, indicating a potential upside of 157.85%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Tilray Brands
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Tilray Brands had 14 more articles in the media than Canopy Growth. MarketBeat recorded 21 mentions for Tilray Brands and 7 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.10 beat Tilray Brands' score of 0.78 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
4 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tilray Brands
10 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Canopy Growth has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market.

Canopy Growth has higher earnings, but lower revenue than Tilray Brands. Canopy Growth is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.72-$190.29M-$0.59N/A
Tilray Brands$821.31M0.63-$2.19B-$13.65N/A

Canopy Growth has a net margin of -75.27% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-75.27% -26.95% -17.20%
Tilray Brands -156.51%-3.31%-2.42%

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Comparatively, 0.8% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Tilray Brands beats Canopy Growth on 11 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Tilray Brands (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Cronos Group has a net margin of -1.14% compared to Tilray Brands' net margin of -156.51%. Cronos Group's return on equity of -1.26% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-156.51% -3.31% -2.42%
Cronos Group -1.14%-1.26%-1.20%

Cronos Group has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$821.31M0.63-$2.19B-$13.65N/A
Cronos Group$146.59M7.00-$9.45M$0.01275.00

Tilray Brands currently has a consensus target price of $11.50, suggesting a potential upside of 157.85%. Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 16.36%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25
Cronos Group
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

In the previous week, Tilray Brands had 20 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 1 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.96 beat Tilray Brands' score of 0.78 indicating that Cronos Group is being referred to more favorably in the news media.

Company Overall Sentiment
Tilray Brands Positive
Cronos Group Positive

Tilray Brands has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.8% of Tilray Brands shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Comparatively, 0.8% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Tilray Brands had 20 more articles in the media than Organigram Global. MarketBeat recorded 21 mentions for Tilray Brands and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.89 beat Tilray Brands' score of 0.78 indicating that Organigram Global is being referred to more favorably in the media.

Company Overall Sentiment
Organigram Global Very Positive
Tilray Brands Positive

Organigram Global has higher earnings, but lower revenue than Tilray Brands. Organigram Global is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organigram Global$185.07M0.68-$17.70M-$0.13N/A
Tilray Brands$821.31M0.63-$2.19B-$13.65N/A

Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 157.85%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Organigram Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Tilray Brands
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

Organigram Global has a net margin of -9.22% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Organigram Global-9.22% -13.41% -9.09%
Tilray Brands -156.51%-3.31%-2.42%

Organigram Global has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.89, indicating that its stock price is 89% more volatile than the broader market.

Summary

Tilray Brands beats Organigram Global on 9 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to SNDL?

SNDL (NASDAQ:SNDL) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

SNDL has a net margin of -1.19% compared to Tilray Brands' net margin of -156.51%. SNDL's return on equity of -1.02% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-1.19% -1.02% -0.85%
Tilray Brands -156.51%-3.31%-2.42%

SNDL currently has a consensus target price of $5.00, indicating a potential upside of 281.68%. Tilray Brands has a consensus target price of $11.50, indicating a potential upside of 157.85%. Given SNDL's higher probable upside, equities research analysts plainly believe SNDL is more favorable than Tilray Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tilray Brands
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Tilray Brands had 20 more articles in the media than SNDL. MarketBeat recorded 21 mentions for Tilray Brands and 1 mentions for SNDL. SNDL's average media sentiment score of 1.87 beat Tilray Brands' score of 0.78 indicating that SNDL is being referred to more favorably in the media.

Company Overall Sentiment
SNDL Very Positive
Tilray Brands Positive

SNDL has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market.

9.4% of Tilray Brands shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

SNDL has higher earnings, but lower revenue than Tilray Brands. SNDL is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$677.32M0.50-$11.29M-$0.03N/A
Tilray Brands$821.31M0.63-$2.19B-$13.65N/A

Summary

Tilray Brands beats SNDL on 9 of the 16 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$515.15M$8.82B$7.05B$12.61B
Dividend YieldN/A2.54%2.68%8.00%
P/E Ratio-0.3316.0927.1524.26
Price / Sales0.637.04587.92117.88
Price / Cash3.0618.4029.2249.36
Price / Book0.323.5710.756.29
Net Income-$2.19B$228.19M$3.58B$330.66M
7 Day Performance3.48%-2.31%-2.07%-1.32%
1 Month Performance-10.44%-0.62%3.31%-0.64%
1 Year Performance-32.10%-2.73%26.35%19.08%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
2.6599 of 5 stars
$4.46
+0.9%
$11.50
+157.8%
-23.2%$515.15M$821.31MN/A2,842
ACB
Aurora Cannabis
1.3273 of 5 stars
$2.68
-1.3%
N/A-40.5%$164.08M$247.82MN/A1,028
CGC
Canopy Growth
1.3239 of 5 stars
$0.97
+0.5%
N/A-15.0%$432.73M$251.01MN/A1,128
CRON
Cronos Group
1.6123 of 5 stars
$2.74
-0.9%
$2.30
-15.9%
+31.6%$1.02B$146.59M273.77450
OGI
Organigram Global
1.4515 of 5 stars
$0.96
-2.9%
N/A-38.2%$135.20M$185.07MN/A1,139

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners